Southern RNA's Co Cap™ A , is a novel co-transcriptional capping reagent designed for mRNA synthesis. Co Cap™ A provides a robust 5' cap 1 structure, enhancing mRNA stability and translational efficiency. ✅ License-free & FTO, seamlessly integrated into the IVT process ✅ Requires a modified T7 RNA polymerase promoter. ✅ Full Quality Control testing complete with CoA ✅ GMP Compliant ✅ 24 month stability data ✅If you would like to receive a free trial sample for evaluation, reach out to us to discuss - Info@southernRNA.com.au Learn more about this cutting-edge solution at https://lnkd.in/g4gJTR-H #mRNA #Research #Innovation #SouthernRNA #NothernRNA #CoCapA #IVT #RNA
Southern RNA 🧬
Biotechnology Research
Springfield Central, Queensland 3,644 followers
Advancing a better future
About us
We are a Australian contract development and manufacturing organisation (CDMO) specialising in the production of nucleic acid products (mRNA) that support life-enabling work. We support our customers by providing scalable manufacturing capacity and help them accelerate innovation in bringing their products from benchtop to bedside or field. Developing and deploying our state-of-the-art bioprocessing and chemical process technologies, using proprietary manufacturing approaches, employing a highly-skilled Australian workforce.
- Website
-
http://www.southernrna.com.au
External link for Southern RNA 🧬
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Springfield Central, Queensland
- Type
- Privately Held
- Founded
- 2021
- Specialties
- messenger RNA, lipid nanoparticles, plasmidDNA, mRNA, vaccines, COVID-19 Vaccine, Cancer, nucleic acid, sequence design, next-generation sequencing, IVT, Linear Plasmid DNA, Co Cap A, Co Transcriptional Capping, Bio Processing, Supercoiled Plasmid DNA , Method development, Vaccine design, Quality Control and Analytical Testing , and Co Cap™ A
Products
Locations
-
Primary
6 Yoga Way
Springfield Central, Queensland 4300, AU
Employees at Southern RNA 🧬
-
Abdul Hye
Commissioning, Qualification & Validation (CQV) | Asset Management | Pharmaceutical Engineering | Project Management | Process Improvement
-
Ben Lewis
Head of Operations and Analytics - Southern RNA
-
Jumai Abioye, PhD
Founder & CEO | Business Builder | Lean and Agile Invention Commercialization and Operations
-
Gabrielle Woodbridge
Award-Winning UQ MBA Graduate | Strategic CMO | Founder and CEO of BlueBlock | Ex- SAP | Expert in B2B Marketing, Commercial Strategy & Customer…
Updates
-
Southern RNA winning the Merck Life Science ‘Emerging Biotech 2024’ award at AusBiotech 2024. Romain Tropée accepted the team award for the ‘enablement of manufacturing personalised medicines through #mRNA’. #AusBio24
-
Day one wrapped up at AusBiotech 2024. Team SRNA and team Providence Therapeutics 🤝
-
Day 1 of AusBiotech 2024. We are stationed at the Queensland Government exhibition booth. Come speak with us on how we can support your RNA projects.
-
Southern RNA's Co Cap™ A , is a novel co-transcriptional capping reagent designed for mRNA synthesis. Co Cap™ A provides a robust 5' cap 1 structure, enhancing mRNA stability and translational efficiency. ✅ License-free & FTO, seamlessly integrated into the IVT process ✅ Requires a modified T7 RNA polymerase promoter. ✅ Full Quality Control testing complete with CoA ✅ GMP Compliant ✅ 24 month stability data ✅If you would like to receive a free trial sample for evaluation, reach out to us to discuss - Info@southernRNA.com.au Learn more about this cutting-edge solution at https://lnkd.in/g4gJTR-H #mRNA #Research #Innovation #SouthernRNA #NothernRNA #CoCapA #IVT #RNA
-
Exciting Times at Southern RNA: Shaping the Future of Personalised Medicine We’re excited to share a glimpse of the groundbreaking work underway at Southern RNA as we embark on the next chapter of our journey—closing the gap in manufacturing personalised medicines with the launch of our bespoke GMP mRNA facility. At SRNA, we are committed to unlocking the full potential of RNA therapeutics. From pioneering research to scalable production geared towards commercial success, our team is at the forefront of developing RNA-based solutions that have the potential to treat a wide range of infectious and chronic diseases. With the opening of our state-of-the-art GMP facility, we’re taking this mission to new heights. The purpose-built facility is designed to deliver customised, high-quality, and GMP-compliant solutions for personalised medicine. By offering a fit-for-purpose manufacturing infrastructure to client developing tailored therapies, SRNA pledges to help its partner turn their vision of personalised healthcare into reality. We’re proud of how far we've come, and we’re just getting started. Let's shape the future of medicine together, get in touch now www.southernrna.com.au #mrna #GMP #manufacturing #RNA #CDMO #madeinaustralia
-
𝗦𝗼𝘂𝘁𝗵𝗲𝗿𝗻 𝗥𝗡𝗔 𝗔𝗻𝗻𝗼𝘂𝗻𝗰𝗲𝘀 𝗖𝗵𝗿𝗶𝘀 𝗣𝗲𝗰𝗸 𝗮𝘀 𝗖𝗘𝗢 We're thrilled to welcome Chris Peck as Southern RNA’s new Chief Executive Officer, effective immediately. Chris transitions from his role as Non-Executive Director, bringing decades of senior leadership experience in advanced manufacturing, and international markets. Under Chris's leadership, we are excited to accelerate our growth in mRNA manufacturing and personalised medicine, continuing to push innovation and expand our global footprint. "𝙄'𝙢 𝙝𝙤𝙣𝙤𝙪𝙧𝙚𝙙 𝙩𝙤 𝙡𝙚𝙖𝙙 𝙎𝙤𝙪𝙩𝙝𝙚𝙧𝙣 𝙍𝙉𝘼 𝙙𝙪𝙧𝙞𝙣𝙜 𝙩𝙝𝙞𝙨 𝙚𝙭𝙘𝙞𝙩𝙞𝙣𝙜 𝙥𝙝𝙖𝙨𝙚 𝙤𝙛 𝙜𝙧𝙤𝙬𝙩𝙝," said Chris. #mRNA #leadership #executive #RNA
-
Southern RNA is excited to participate in AusBiotech 2024, taking place in Melbourne from October 30th to November 1st. This year, we will be stationed at the Queensland Government booth, supported by the Department of State Development and Infrastructure’s Biomedical Sector Team. Garry Heaney, Tara Buse & Romain Tropée will be in attendance and available to meet via the partnering app. Join us as we connect with industry leaders, explore pioneering research, and share our progress in RNA-based solutions. We are eager to engage with peers and cultivate partnerships that shape the future of biotechnology. #AusBiotech2024 #BiotechInnovation #RNAresearch #BiotechConference #QueenslandGovernment #BiomedicalSector #CollaborationInScience #mRNA
-
Day 1 at The Bioprocessing Network comes to an end. SRNA mRNA lead Jonathan Peters delivered a great talk which was well received with lots of positive feedback. It was great to catch up with industry peers, which really demonstrates how vibrant the biotech landscape is becoming in Australia.
-
Attending The Bioprocessing Network this week? Be sure not to miss our mRNA lead Jonathan Peters who will be discussing 'How #pDNA Quality and Downstream, Impacts on #mRNA Product Profile'